Susan Connor
Overview
Explore the profile of Susan Connor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
1240
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cosier D, Lambert K, Charlton K, Batterham M, Little R, Wu N, et al.
Nutrients
. 2025 Jan;
16(24).
PMID: 39770970
Background: Few studies have explored the relationship between habitual dietary patterns and disease activity in people with Inflammatory Bowel Disease (IBD). This cross-sectional study explored the association between dietary patterns...
2.
Jacob R, Chu V, Ng W, Williams A, Connor S
Intern Med J
. 2024 Oct;
54(12):2009-2014.
PMID: 39422325
Background: The incidence of Clostridioides difficile infection (CDI) in inflammatory bowel disease (IBD) is rising and associated with adverse outcomes. Optimal treatment for CDI in IBD remains unknown, with various...
3.
Chan P, Connor S, Huang V, Karimi N, Williams A
Aliment Pharmacol Ther
. 2023 Jun;
58(1):141-142.
PMID: 37307542
No abstract available.
4.
Wu Y, Wen A, Selvanderan S, Xuan W, Andrews J, Koo J, et al.
Crohns Colitis 360
. 2023 Feb;
3(3):otab042.
PMID: 36776656
Background: There is controversy about the proactive clinical application of therapeutic drug monitoring (TDM) of biologic drugs in Crohn's disease (CD). One way to practically assess this is to examine...
5.
Gu B, Venkatesh K, Williams A, Ng W, Corte C, Gholamrezaei A, et al.
World J Gastroenterol
. 2022 Aug;
28(23):2597-2608.
PMID: 35949350
Background: Tumor necrosis factor-alpha inhibitors, including infliximab and adalimumab, are effective medical treatments for perianal fistulising Crohn's disease (CD), but not all patients achieve fistula healing. Aim: To determine the...
6.
Barnes A, Ooi S, Lynch K, Parthasarathy N, Bishara M, Gounder M, et al.
Dig Dis Sci
. 2022 Jun;
68(3):889-896.
PMID: 35687221
Background: The thiopurine medications are well established in the treatment of inflammatory bowel disease (IBD). There is significant variation in levels of toxic and therapeutic metabolites. Current data from small...
7.
Wang G, Karimi N, Willmann L, Pipicella J, Descallar J, OConnor K, et al.
Dig Dis Sci
. 2022 May;
67(9):4303-4314.
PMID: 35499712
Background: Women with inflammatory bowel disease (IBD) with poor IBD-specific reproductive knowledge experience more childlessness and fear of IBD medications in pregnancy. The Pregnancy in IBD Decision Aid (PIDA), developed...
8.
Barnes A, Carter D, Kaazan P, Walsh A, Connor S, Andrews J
Intest Res
. 2022 Apr;
20(4):506-508.
PMID: 35462527
No abstract available.
9.
Byrne P, Connor S
Nurs Educ Perspect
. 2022 Feb;
43(6):E79-E81.
PMID: 35113080
Between 2015 and 2018, nurse faculty replaced a medical-based curriculum with a concept-based curriculum. NCLEX®-RN pass rates and a nontraditional program quality indicator assessed the association of different curricula on...
10.
Rao G, Connor S
J Racial Ethn Health Disparities
. 2022 Jan;
10(2):536-541.
PMID: 35088391
Objective: Adult cardiovascular disease has its roots in childhood and adolescence. Risks for pediatric hypertension include obesity, male sex, and minority race. We identified risk factors associated with hypertension specifically...